Yahoo Web Search

Search results

1. • 

     HPV vaccine reduces head and neck cancer risk in men by more than 50%

     Medical News Today· 14 hours ago

     A new analysis suggests the HPV vaccine may be more effective in males than in females. Many people...

2. • 

     HPV vaccine can reduce risk of multiple cancers in men, new study suggests

     ABC News via Yahoo News· 5 days ago

     Nearly two decades after the launch of the first HPV vaccine, mounting evidence shows that people...

3. • 

     Have you ever had a 'ghost poop'? Here's what that says about your health

     TODAY via Yahoo News· 5 days ago

     Potential causes include inflammatory bowel disease, Crohn's, colorectal polyps, and anal cancer,...

4. • 

     Tenesmus

     Health via Yahoo News· 4 days ago

     The protruding tissue can cause bowel movements to feel incomplete. Hemorrhoids and anal fissures can cause tenesmus due to the irritation ...

5. • 

     HPV Vaccine Offers Cancer Protection Beyond Cervical Cancer

     Medscape· 4 days ago

     HPV vaccination protects not only against cervical cancer in women but also other HPV-related ...

6. • 

     Ironman Athlete Patricia Salazar Says Surviving Cervical Cancer 'Gave Me Confidence' (Exclusive)

     People via Yahoo News· 4 days ago

     Springs, Utah. She encourages women to advocate for themselves and for young people to get the HPV...

7. • AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024

     Morningstar· 7 days ago

     Data From Newly FDA-Approved IMDELLTRA™ (tarlatamab-dlle) Further Reinforce Leadership in Bispecific T-Cell Engagers Overall Survival Data from Phase 3 LUMAKRAS® (sotorasib) Plus Vectibix® ( ...

8. • 

     Study finds HPV vaccine can lower multiple cancer risks in adults

     WXYZ-TV Detroit· 4 days ago

     HPV is a widespread viral infection behind an estimated 690,000 cancer cases globally each year....

9. • AbbVie Showcases Robust Solid Tumor Pipeline at ASCO 2024 with New Data from Its Innovative...

     WROC Rochester· 7 days ago

     New safety and efficacy data in heavily pre-treated patients with metastatic colorectal cancer (CRC), from a Phase 1 study of ABBV-400, a next-generation, potential best-in-class ...

10. • Small Business - Salisbury Post | Salisbury Post

      The Salisbury Post· 1 day ago

      “As our company is now increasingly focused on our lead asset petosemtamab and plan to initiate phase 3 trials in head and neck cancer later this year, we aim to advance clinical ...